Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GNC sales increase

This article was originally published in The Tan Sheet

Executive Summary

General Nutrition Centers sales advanced 6.7 percent in 2008 to $1.66 billion, the Pittsburgh-based nutritional supplements retailer announces March 19. Earnings before income taxes, depreciation and amortization for the year were $212.2 million, compared to $125.5 million in 2007, when the firm absorbed a number of costs associated with the 2007 acquisition of the firm's parent company (1"The Tan Sheet" Feb. 12, 2007, p. 9). In the fourth quarter, consolidated revenues increased 4.2 percent to $391.7 million, with growth recorded in each of the firm's business segments. Fourth quarter EBITDA was relatively flat at $45.8 million, the firm says

You may also be interested in...



GNC To Be Acquired For $1.65 Bil. By Ares, Ontario Teachers’ Pension Plan

Ares Management and the Ontario Teachers' Pension Plan private investment groups have agreed to purchase the parent company of vitamin and nutritional supplement firm GNC for $1.65 billion, the firms announce Feb. 9

Moderna Stands Alone With Single-Antigen Approach To COVID-19 Vaccine

Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.

Kansas City TCM Firm Persists With COVID-19 Claims Following US Regulators' Warning

Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.

Topics

UsernamePublicRestriction

Register

PS102732

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel